Clinical and Genetic Characterization of a Family with Hereditary Factor X Deficiency Carrying Compound Heterozygous p.Phe71Ser and p.Val424Phe Variants in the F10 Gene
Hämostaseologie · 2026-11-03
DOI: 10.1055/a-2985-5598 ↗Abstract
Abstract Introduction Hereditary factor X (FX) deficiency is a rare bleeding disorder caused by pathogenic variants in the F10 gene. We report the case of an 86-year-old female proband who was diagnosed with hereditary FX deficiency during preoperative evaluation for upper abdominal discomfort. Methods Phenotypic and genetic analyses were performed on seven individuals across three generations of the proband’s family. Coagulation parameters were assessed by one-stage clotting assays. All exons and flanking sequences of the F10 gene were amplified by PCR and subjected to Sanger sequencing. Bioinformatic tools were employed to evaluate the functional impact, pathogenicity, structural consequences, and evolutionary conservation of the identified variants. Results The proband exhibited significantly prolonged prothrombin time (33.3 s) and activated partial thromboplastin time (47.7 s), along with markedly reduced FX activity (3%). Thrombin generation was impaired in the proband and her children compared to healthy controls. Genetic analysis identified two heterozygous missense variants: c.212T>C (p.Phe71Ser) in exon 2, located within the Gla domain β-sheet core, which may disrupt hydrogen bonding and calcium-binding sites; and c.1270G>T (p.Val424Phe) in exon 8, which may introduce steric hindrance in the catalytic domain. Both variants were predicted to be pathogenic, and the affected residues are evolutionarily conserved. Conclusion The FX deficiency in this family is associated with heterozygous p.Phe71Ser and p.Val424Phe variants in the F10 gene, which may potentially impair protein structure and coagulation function.
EUVIMED